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Electrospinning is a well-known process for producing submicrometer fibers, which have wide applications in many fields, espe-
cially in tissue engineering scaffolds and drug-delivery systems. This paper presents the formation of drug-loaded electrospun 
twin fibers. The correlations between the twin fiber formation and the polymer materials or the loaded drugs were studied by us-
ing poly(l-lactide) and poly(l-lactide-co-glycolide) as electrospinning materials, and rifampin and paclitaxel as loaded drugs. 
Scanning electron microscopy showed that the formation of twin fibers is significantly affected by the loaded drug but not the 
polymer material. A possible reason for twin fiber formation was analyzed.  
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Electrospinning is a well-known process [1–4] for produc-
ing micro- or nanofibers for use as tissue engineering scaf-
folds, drug controlled-release carriers, filtration, and bio-
sensors. The materials used and the preparation conditions 
influence the shape of the ultrafine fibers formed. To date, 
several kinds of electrospun fibers have been prepared, in-
cluding ultrafine fibers with beads on the string [5,6], fibers 
with ribbon cross-sections [7,8] and in particular, fibers 
with round cross-sections [9–11]. Furthermore, electrospun 
fibers with nanopores on the fiber surface have been pre-
pared and characterized [12–15]. Recently, Varesano et al. 
[16] fabricated crimped polymer nanofibers by air-driven 
electrospinning.  
One of the most important medical applications of elec-
trospun ultrafine fibers is their use as drug controlled re-
lease carriers. Although there are limited studies on this 
application, it has attracted increasing attention [17–21]. For 
example, Tungprapa et al. [17] examined the release char-
acteristics of four model drugs from drug-loaded electro-
spun cellulose acetate fiber mats. The results showed that 
the release rate of the four model drugs from the drug- 
loaded electrospun cellulose acetate fiber mats were greater 
than that from the corresponding as-cast films. Zeng and 
co-workers [18,19] explored the preparation of rifampin- 
loaded electrospun PLLA fibers and later studied the influ-
ence of the drug compatibility with the polymer solution on 
the release kinetics of such electrospun fiber formulations. 
It showed that the burst release of the drug can be avoided 
by using compatible drugs with polymers and that drug re-
lease can follow nearly zero-order kinetics due to degrada-
tion of the PLLA fibers in the presence of proteinase K. 
This paper presents the formation of drug-loaded elec-
trospun twin fibers. The correlations between the twin fiber 
formation and the polymer materials used for electrospin-
ning or the loaded drugs were studied and a possible mech-
anism for twin fiber formation analyzed. The results have 
great significance for designing and preparing new drug 
controlled-release systems and for further study into the 
mechanisms of drug controlled release. 
1  Materials and methods 
Poly(l-lactide) (PLLA) and poly(l-lactide-co-glycolide) (PLGA) 
(80/20 in weight) were synthesized in our lab. The viscosity 
average molecular weight of PLLA was 225 kg/mol. The 
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intrinsic viscosity of PLGA (80/20) was 2.0. Rifampin (a 
drug for tuberculosis, Sinopharm Chemical Reagent Co., 
Ltd, Shenyang, China) and paclitaxel (an anti-cancer drug, 
Huiang Biochemical Reagent Co., Ltd, Guilin, China) were 
commercial products. Chloroform and acetone (Sinopharm 
Chemical Reagent Co., Ltd) were of analytical purity.  
A 2:1 (v/v) mixture of chloroform and acetone was used 
as the solvent for PLLA and 4:3 (v/v) for PLGA. The poly-    
mer concentrations of PLLA and PLGA were 3.9 wt% and 
6.6 wt%, respectively. Different amounts of rifampin (5 wt%– 
100 wt%) and paclitaxel (5 wt%–50 wt%) were added to the 
solution. Weight percentages are expressed relative to the 
polymer content. 
The electrospinning arrangement is shown in Figure 1. 
The polymer solution was added in a 5-mL syringe with a 
right angle-shaped metal capillary attached. The circular 
orifice of the capillary had an inner diameter of 0.4 mm. A 
round counter electrode was located about 20 cm from the 
capillary tip. A pressure was applied to the solution in the 
syringe by placing a particular weight on the top of the pis-
ton to maintain a steady flow of the solution from the capil-
lary outlet. The applied voltage was in the range 30–45 kV. 
The morphology of the electrospun fibers was observed 
with a scanning electron microscope (SEM; JXA-840 from 
JEOL) at an accelerating voltage of 20 kV. 
2  Results and discussion 
Figure 2 shows SEM photographs of PLLA electrospun 
fibers containing different amounts of rifampin. It can be 
seen that only single electrospun fibers were obtained at  
 
Figure 1  A diagram of the electrospinning system. 1, Polymer solution;   
2, syringe pump; 3, capillary nozzle; 4, high voltage generator; 5, jet;     
6, collector; 7, grounding; 8, dried electrospun fibers. 
15 wt% rifampin (Figure 2(a)). However, when at 30 wt% 
rifampin, twin fibers were observed in the SEM photograph, 
as can be seen in Figure 2(b). Clearly, formed twin fibers 
were also formed with increasing rifampin content (Figure 
2(c)–(e)). The percentage of the generated twin fibers relat-
ed to the rifampin content was calculated by dividing the 
number of twin fibers by the total number of the fibers in 
the SEM photographs, and the data were averaged from 
three replicates. The results are shown in Figure 3(a). Ap-
proximately 50% twin fibers was obtained (Figure 2(c)) 
when adding 50 wt% rifampin to the PLLA/chloroform- 
acetone solution, while only 20% twin fibers was observed 
at 30 wt% rifampin. When 100 wt% rifampin was added to  
 
Figure 2  SEM photographs of PLLA electrospun fibers containing different amounts of rifampin. (a) 15 wt%; (b) 30 wt%; (c) 50 wt%; (d) 100 wt%, 
5000 magnification; (e) 100 wt%, 10000× magnification. The rifampin content is given relative to PLLA content. Staff guage: 1 m. 
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Figure 3  The percentage of the formed twin fibers with different amounts of rifampin in PLLA (a) and PLGA(80/20) (b) solutions.  
the PLLA electrospinning solution, almost all of the fibers 
were twin formed (Figure 2(d) and (e)).  
To explore whether or not twin fiber formation was re-
lated to the polymers used for electrospinning, PLGA was 
chosen for loading rifampin during electrospinning. As 
shown in Figure 4(b), an obvious tendency to form twin 
fibers was observed at 15 wt% rifampin while no such phe-
nomenon was seen at 5 wt% rifampin (Figure 4(a)). Using 
the calculation procedure described above, the percentage of 
twin fibers formed also increased with increasing rifampin 
content (Figure 3(b)). It can be seen in Figure 4(c) and (d) 
that nearly half of the electrospun fibers were twin formed 
when the rifampin content reached 50 wt%. It can therefore 
be concluded that twin fibers formation had little relation to 
the above two polymer materials used for electrospinning. 
To determine whether the generation of twin fibers was 
correlated to the loaded drug, paclitaxel was utilized as an 
alternative drug for incorporaton into the PLLA electrospun 
fibers. It was shown that no twin fibers resulted even when 
the paclitaxel content reached 50 wt%, as shown in Figure 5. 
Therefore, the loaded drug significantly affected twin fiber 
formation, although it was probably only one of the factors 
affecting twin fiber generation. 
The characteristics of the electrospinning polymer/drug 
solutions are shown in Table 1. Whether the viscosity or the 
conductivity was in the same level, as shown in Table 1, so 
the electrospinning fibers from these polymer/drug solutions  
 
Figure 4  SEM photographs of PLGA(80/20) electrospun fibers contain-
ing different amounts of rifampin. (a) 5 wt%; (b) 15 wt%; (c) 50 wt%, 
5000× magnification; (d) 50 wt%, 10000× magnification. The rifampin 
content is given relative to PLGA (80/20). Staff guage: 1 m. 
were comparable. 
The difference between the drug influences on the for-
mation of twin fibers is probably related to their hydrophilic 
or hydrophobic properties. Rifampin has an amphipathic 
structure, and the hydrophilic property may lead to a fast 
phase separation. Paclitaxel is a hydrophobic drug, as are 
the PLLA and PLGA polymers, so phase separation may  
 
Figure 5  SEM photographs of PLLA electrospun fibers containing different amounts of paclitaxel. (a) 5 wt%; (b) 15 wt%; (c) 50 wt%. The paclitaxel 
content is given relative to PLLA. Staff guage: (a) 10 m; (b) and (c) 1 m. 
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Table 1  Characteristics of the electrospinning polymer/drug solutions 
Solution Concentration (wt%) Drug Ratio of drug to polymer (wt%) Viscositya) (mPa s) Conductivityb) (S/cm) 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Rifampin 15 105 0.12 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Rifampin 30 103 0.16 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Rifampin 50 100 0.15 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Rifampin 100 99 0.17 
PLGA/chloroform-acetone 
(4:3, v/v) 6.6 Rifampin 5 103 0.15 
PLGA/chloroform-acetone  
(4:3, v/v) 6.6 Rifampin 15 100 0.13 
PLGA/chloroform-acetone 
(4:3, v/v) 6.6 Rifampin 50 99 0.16 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Paclitaxel 5 99 0.15 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Paclitaxel 15 100 0.15 
PLLA/chloroform-acetone 
(2:1, v/v) 3.9 Paclitaxel 50 102 0.16 
a) The viscosity of the electrospinning polymer/drug solutions was measured at 20°C by an Ubbelodhe viscometer. b) The conductivity of the electro-
spinning polymer/drug solutions was measured at 20°C with a conductivity meter (DDS-307, Shanghai, China). The data are an average of three replicates.  
 
Figure 6  Conceptual diagram of the twin fiber formation process. 
not have occurred as readily. Further study on how twin 
fiber formation is related to the loaded drugs is required. 
A possible mechanism for twin fiber formation is as fol-
lows: With increasing rifampin content, the shell layer of 
the semi-formed ultrafine fibers becomes thinner during 
electrospinning. Thus, a shell forms prior to solidification, 
along with evaporation of solvent. However, this initial 
shell layer is very thin, so collapses with further evaporation 
of solvent inside the fibers, thus forming the twin fibers. 
Figure 6 shows a conceptual diagram of the twin fiber for-
mation process. 
3  Conclusions 
The formation of drug-loaded electrospun twin fibers was 
studied using PLLA and PLGA as polymer materials. A 
high rifampin content led to twin fiber formation, regardless 
of whether PLLA or PLGA was used during electrospinning 
and increased rifampin content led to greater twin fiber 
formation. However, no twin fibers were observed when 
PLLA was loaded with paclitaxel. Therefore, it can be con-
cluded that the formation of electrospun twin fibers is sig-
nificantly affected by the nature of the loaded drugs but not 
by the polymer materials. 
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